Current Medicinal Chemistry - Anti-Cancer Agents
Title: Preface [Hot topic:Drug Resistance in Cancer Therapy (Guest Editor: Jian-Ting Zhang)]
Volume: 4 Issue: 1
Author(s): Jian-Ting Zhang
Affiliation:
Export Options
About this article
Cite this article as:
Zhang Jian-Ting, Preface [Hot topic:Drug Resistance in Cancer Therapy (Guest Editor: Jian-Ting Zhang)], Current Medicinal Chemistry - Anti-Cancer Agents 2004; 4 (1) . https://dx.doi.org/10.2174/1568011043482179
DOI https://dx.doi.org/10.2174/1568011043482179 |
Print ISSN 1568-0118 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5968 |
8
Related Articles
-
Towards Second Generation Hypericin Based Photosensitizers for Photodynamic Therapy
Current Organic Chemistry Nanovehicle-based Small Interfering RNA (siRNA) Delivery for Therapeutic Purposes: A New Molecular Approach in Pharmacogenomics
Current Clinical Pharmacology Current Strategies for Probing Substrate Specificity of Proteases
Current Medicinal Chemistry β-Hydroxy-β-Methylbutyrate as a Countermeasure for Cancer Cachexia: A Cellular and Molecular Rationale
Anti-Cancer Agents in Medicinal Chemistry PET in Anti-Cancer Drug Development and Therapy
Recent Patents on Anti-Cancer Drug Discovery Breast Cancer: Understanding Sensitivity and Resistance to Chemotherapy and Targeted Therapies to Aid in Personalised Medicine
Current Cancer Drug Targets Serum Testosterone and Cognitive Function in Ageing Male: Updating the Evidence
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Reduced Lipocalin 2 Expression Contributes to Vincristine Resistance in Human Colon Cancer Cells
Recent Patents on Anti-Cancer Drug Discovery Viral Origins of Human Cancer
Current Medicinal Chemistry Antipsychotics as Psychosis Drugs and Neuroprotective Promoters Evaluated by Chemical QSAR - in silico and in vivo Studies
Letters in Drug Design & Discovery Uncertainty in the Translation of Preclinical Experiments to Clinical Trials. Why do Most Phase III Clinical Trials Fail?
Current Gene Therapy 3D-QSAR Studies on a Series of Inhibitors Docked into a New Homology Model of the DNA-PK Receptor
Current Pharmaceutical Design Heme Oxygenase-1 in Lung Disease
Current Drug Targets Selective Gene Amplification for High-Throughput Sequencing
Recent Patents on DNA & Gene Sequences Transdermal Oxandrolone: Ex Vivo Percutaneous Absorption Study
Current Drug Delivery Brachytherapy: State of the Art and Possible Improvements
Anti-Cancer Agents in Medicinal Chemistry Oncologists Current Opinion on the Treatment of Colon Carcinoma
Anti-Cancer Agents in Medicinal Chemistry The Co-regulatory Role of 5-Lipoxygenase and Cyclooxygenase-2 in the Carcinogenesis and their Promotion by Cigarette Smoking in Colons
Current Medicinal Chemistry Therapeutic Potential of Inhibiting Brutons Tyrosine Kinase, (BTK)
Current Pharmaceutical Design Risk of Cervical Cancer After HPV Vaccination
Current Pharmaceutical Design